Carcinoma, Hepatocellular: all 3,249 studies
Page 26 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT02716766Phase 2
- Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma.Status unknownNCT02715492Phase 3
- A Study of GPC3 Redirected Autologous T Cells for Advanced HCCStatus unknownNCT02715362Phase 1/2
- Resection+Highly Purified CTL Versus Resection Alone for HCCStatus unknownNCT02709070Phase 3
- Evaluation of Performance of Automatic Fusion for Radiofrequency Ablation of Hepatocellular CarcinomaCompletedNCT02705118Not applicable
- Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)WithdrawnNCT02702960Phase 2
- Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical StudyStatus unknownNCT02702323Phase 2/3
- Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected PatientsCompletedNCT02693847
- Exploratory Study to Determine Tissue Alterations of Advanced Hepatocellular Carcinoma Induced by Electromagnetic Waves of Low Energy Amplitude Modulated to Specific Frequencies During Imaging Study by MRICompletedNCT02692365Not applicable
- An Open Study Assessing the Safety and Tolerability of U3-1784TerminatedNCT02690350Phase 1
- A Study of TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver TransplantationCompletedNCT02686372Phase 1
- Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN StudyCompletedNCT02685631
- MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver CancerCompletedNCT02683200Early Phase 1
- Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular InvasionStatus unknownNCT02678806Not applicable
- RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCCStatus unknownNCT02678013Phase 3
- Metformin Plus Sorafenib for Advanced HCCStatus unknownNCT02672488Phase 2
- Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCCCompletedNCT02650271Phase 3
- Single Session Combined Locoregional Therapies for Hepatocellular CarcinomaStatus unknownNCT02646137Phase 3
- Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT02645981Phase 2/3
- Effect of Enhanced Recovery After Surgery(ERAS) After Liver Resection for Primary Liver CancerStatus unknownNCT02644603Not applicable
- Hepatocellular Carcinoma Recurrence and AnesthesiaCompletedNCT02643173
- Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma PatientsCompletedNCT02642913Phase 1
- Proton Radiotherapy Versus Radiofrequency Ablation for Patients With Medium or Large Hepatocellular CarcinomaStatus unknownNCT02640924Phase 3
- Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT02638857Phase 1/2
- Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular CarcinomaStatus unknownNCT02632188Phase 1/2
- Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT02632006Phase 1/2
- Efficacy Study of TACE to Treat Hepatocellular Carcinoma After OperationStatus unknownNCT02631499Phase 4
- TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular CarcinomaStatus unknownNCT02630108Phase 3
- Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver FunctionTerminatedNCT02626312Phase 1
- Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular CarcinomaStatus unknownNCT02616926Not applicable
- HCC Patient Preferences in JapanCompletedNCT02616692
- Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular CarcinomaCompletedNCT02613156
- Gut Microbiota in People With Hepatocellular Carcinoma (HCC)WithdrawnNCT02599909
- Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPHStatus unknownNCT02587884Phase 1
- Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the PatientsCompletedNCT02587793
- Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular CarcinomaStatus unknownNCT02586285Phase 1
- Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular CarcinomaTerminatedNCT02585687Not applicable
- Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular CarcinomaWithdrawnNCT02585479Phase 2/3
- Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular CarcinomaWithdrawnNCT02584556Phase 2/3
- Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5CompletedNCT02582918Not applicable
- Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard DosimetryCompletedNCT02582034Phase 2
- Clinical Study of Effectiveness of Radiotherapy Before Surgery in High-risk Relapse Hepatocellular Cancer PatientsStatus unknownNCT02580929Not applicable
- Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver TransplantationWithdrawnNCT02580253Phase 2
- MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver CancerCompletedNCT02578602Phase 1
- A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver CancerCompletedNCT02576964Phase 2
- A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic MalignanciesCompletedNCT02572687Phase 1
- Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor ThrombosisCompletedNCT02571946Not applicable
- The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving SorafenibStatus unknownNCT02564666Not applicable
- A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult Participants With Hepatocellular Carcinoma (HCC)CompletedNCT02564614Phase 1
- Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid TumorStatus unknownNCT02562963Phase 1/2
- p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular CarcinomaStatus unknownNCT02561546Phase 2
- Correlation Between CT Perfusion and Post Y-90 TARE PET/CT DosimetryWithdrawnNCT02558205
- Randomized Control Trial (RCT) of Early Palliative Care for HCCStatus unknownNCT02556619Not applicable
- Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial ChemoembolizationCompletedNCT02552745
- Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver CirrhosisCompletedNCT02551250
- Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular CarcinomaStatus unknownNCT02550613
- LifePearl-Doxo Pharmacokinetic (PK) StudyCompletedNCT02548780Not applicable
- Annexin A2 as a Novel Diagnostic Marker in Hepatocellular CarcinomaCompletedNCT02541149
- Comparison of Microwave and Radiofrequency Ablation for LiverCompletedNCT02539212Not applicable
- Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical ResectionStatus unknownNCT02537158Not applicable
- A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid TumorsTerminatedNCT02536183Phase 1
- Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCCStatus unknownNCT02535117Phase 4
- Prophylactic Antibiotics Before RFA for HCCStatus unknownNCT02534961Phase 4
- Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular CarcinomaWithdrawnNCT02534337Phase 2/3
- TACE With or Without Sorafenib in Intermediate Stage Hepatocellular CarcinomaStatus unknownNCT02529761Not applicable
- Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary NeoplasmStatus unknownNCT02528526Phase 1/2
- Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular CarcinomaWithdrawnNCT02527772Phase 2/3
- Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection.TerminatedNCT02527577Not applicable
- Laparoscopic Versus Open Liver Resection for Hepatocellular CarcinomaStatus unknownNCT02526043Not applicable
- The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular CarcinomaStatus unknownNCT02525965Not applicable
- Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring SystemStatus unknownNCT02525952Not applicable
- Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT02525380Phase 4
- Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma PatientsStatus unknownNCT02523053Not applicable
- 11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARECompletedNCT02519075
- Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]Status unknownNCT02514434Not applicable
- Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing SurgeryCompletedNCT02511821Not applicable
- Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT02509169Phase 2
- A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular CarcinomaCompletedNCT02508467Phase 1
- Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular CarcinomaStatus unknownNCT02507882Not applicable
- Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT02507765Phase 1
- Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular CarcinomaStatus unknownNCT02504983Phase 4
- Hepatocellular Cancer (HCC) Screening in Zhongshan CityActive, not recruitingNCT02501980
- Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular CarcinomaCompletedNCT02489838
- DC-CIK Combined With TACE in the Treatment of Hepatocellular CarcinomaStatus unknownNCT02487017Phase 2
- A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular CarcinomaTerminatedNCT02482909Not applicable
- Assessment of Frailty in Patients With Advanced Hepatocellular CancersCompletedNCT02482259
- Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCCCompletedNCT02472249Phase 4
- Transarterial Chemoembolization Versus Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaTerminatedNCT02470533Phase 2
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
- HR Combined With FOLFOX4 for HCC With PVTTStatus unknownNCT02452853Phase 2
- Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver CarcinomaCompletedNCT02449109Phase 1/2
- Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma RecurrenceCompletedNCT02447679Phase 2
- Surefire Catheter Versus Standard End-hole Microcatheter: A Pilot StudyTerminatedNCT02446925Not applicable
- Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune ResponseTerminatedNCT02439008Not applicable
- Simo Decoction and Gum Chewing for Bowel ActivityCompletedNCT02438436Phase 3
- Adjuvant Therapies for Patients With HCC and MVIStatus unknownNCT02436902Phase 3
- HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCCApproved for marketingNCT02436044
- TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular CarcinomaCompletedNCT02435953Phase 3
- Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyActive, not recruitingNCT02432963Phase 1
- RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCCStatus unknownNCT02426450Phase 2